Update your practical skills and theoretical knowledge about gut, genitourinary, and skin bacterial flora with this program designed by TECH to meet your needs"

With the scientific and technological evolution in the field of health, discoveries about the Human Microbiota constantly occur. At the same time, these advances have contributed to the appearance of new procedures to control or influence the development of pathologies caused by some of these microorganisms. In the case of the bacterial flora of the skin, for example, new and better therapeutic strategies have appeared for the intervention of Psoriasis and Atopic Dermatitis. Despite all these advances, nursing professionals find it difficult to keep up with them. This is due to the fact that most educational programs do not delve into the practical applications of the new care protocols derived from this health research. For this reason, the demand from professionals in the sector is for qualifications that help them to update their skills quickly, flexibly, and in line with their needs.

In this context, TECH has devised a Hybrid professional master’s degree of the highest demand and quality. It has been conceived to provide the student with the most recent Nursing procedures regarding the intervention of patients with bacterial flora-related conditions. The program implements an innovative methodology, divided into two fundamental phases. The first stage will be 100% online and will include 10 comprehensive Masterclasses delivered by a pioneer in scientific research related to the Human Microbiota. An International Guest Director renowned for his active practice and specialized findings.

In the second educational period, the nurse will develop a first level clinical practice, from a hospital facility with optimal health care equipment. These care tools are in line with the latest scientific evidence for the care of patients with diseases generated by microorganisms. The internship, with an on-site and intensive nature, will have a duration of 3 weeks and, at all times, will be supervised by leading experts. At the same time, an assistant tutor will be in charge of monitoring all academic progress and inserting dynamic assignments throughout the program.

A comprehensive program that integrates 10 exclusive Masterclasses, delivered by a prestigious International Guest Director, completely dedicated to the research of the Human Microbiota” 

This Hybrid professional master’s degree in Human Microbiota for Nursing contains the most complete and up-to-date scientific program on the market.The most important features include: 

• Development of more than 100 clinical cases presented by nursing professionals with expertise in Human Microbiota
• Its graphic, schematic and practical contents provide scientific and assistance information on those medical disciplines that are essential for professional practice
• Presentation of practical workshops on procedures, diagnosis, and treatment techniques in critical patients
• An algorithm-based interactive learning system for decision making in the clinical situations presented
• Practical clinical guides on approaching different disorders
• All of this will be complemented by theoretical lessons, questions to the expert, debate forums on controversial topics, and individual reflection assignments
• Content that is accessible from any fixed or portable device with an Internet connection
• Furthermore, you will be able to carry out a clinical internship in one of the best hospital centers

Through 1,920 hours of study, this Hybrid professional master’s degree guarantees the graduate an up-to-date, high-quality program that will help them to manage the most complex equipment and care protocols currently used to treat Microbiota diseases"

In this Hybrid professional master’s degree, with a vocational nature and blended learning modality, the program is aimed at updating nursing professionals who require a high level of qualification. The content is based on the latest scientific evidence and is organized in a didactic way to integrate theoretical knowledge into nursing practice. The theoretical-practical elements allow professionals to update their knowledge and help them to make the right decisions in patient care.

Thanks to the multimedia content, developed with the latest educational technology, nursing professionals will benefit from situated and contextual learning, i.e., a simulated environment that will provide immersive learning programmed to train in real situations. This program is designed around Problem-Based Learning, whereby the professional must try to solve the different professional practice situations that arise throughout the program. For this purpose, students will be assisted by an innovative interactive video system created by renowned and experienced experts.

With this Hybrid professional master’s degree, you will analyze rigorously up-to-date educational modules under the careful supervision of the best teaching faculty"

The clinical practices of this program to be carried out in an on-site and intensive way, will allow the nurse to develop skills in a direct way in the assistance of patients with real diseases"

This TECH syllabus has the most up-to-date knowledge on the Human Microbiota. In this way, Nursing professionals will be able to update their competencies to comprehensively assist patients suffering from diseases related to intestinal, oral, or genitourinary tract microorganisms. The syllabus also delves into the bacterial flora of the skin and all the factors that regulate it. In addition, it delves into the different allergies and intolerances that may be related to this class of pathogens. For the learning of all these contents, graduates will have at their disposal theoretical materials and multimedia resources of great didactic value. Furthermore, they will be taught 100% online with first-class pedagogical methods such as Relearning.

100% online and interactive: this is the TECH platform where you will find the most up-to-date theoretical materials related to the study of the Human Microbiota for Nursing"

Module 1. Microbiota. Microbiome. Metagenomics

1.1. Definition and Relationship Between Them
1.2. Composition of the Microbiota: Types, Species and Strains

1.2.1. Groups of Microorganisms that Interact with Humans: Bacteria, Fungi, Viruses, and Protozoa
1.2.2. Key Concepts: Symbiosis, Commensalism, Mutualism, Parasitism
1.2.3. Autochthonous Microbiota

1.3. Different Human Microbiota. General Overview of Eubiosis and Dysbiosis

1.3.1. Gastrointestinal Microbiota
1.3.2. Oral Microbiota
1.3.3. Skin Microbiota
1.3.4. Respiratory Tract Microbiota
1.3.5. Urinary Tract Microbiota
1.3.6. Reproductive System Microbiota

1.4. Factors that Influence Microbiota Balance and Imbalance

1.4.1. Diet and Lifestyle. Gut-Brain Axis
1.4.2. Antibiotic Therapy
1.4.3. Epigenetic-Microbiota Interaction. Endocrine Disruptors
1.4.4. Probiotics, Prebiotics, Symbiotics. Concepts and Overviews
1.4.5. Fecal Transplant, Latest Advances

Module 2. Gut Microbiota I. Intestinal Homeostasis

2.1. Gut Microbiota Studies

2.1.1. Projects MetaHIT, Meta-Biomed, MyNewGut, Human Microbiome Project

2.2. Microbiota Composition

2.2.1. Protective Microbiota (Lactobacillus, Bifidobacterium, Bacteroides)
2.2.2. Immunomodulatory Microbiota (Enterococcus faecalis and Escherichia coli)
2.2.3. Mucoprotective or Muconutritive Microbiota (Faecalibacterium prausnitzii and Akkermansia muciniphila)
2.2.4. Microbiota with Proteolytic or Proinflammatory Activities (E. coli Biovare, Clostridium, Proteus, Pseudomonas, Enterobacter, Citrobacter, Klebsiella, Desulfovibrio, Bilophila)
2.2.5. Fungal Microbiota (Candida, Geotrichum)

2.3. Digestive System Physiology. Composition of the Microbiota in the Different Parts of the Digestive Tract. Resident Flora and Transient or Colonizing Flora. Sterile Areas in the Digestive Tract

2.3.1. Esophageal Microbiota

2.3.1.1. Healthy Individuals
2.3.1.2. Patients (Gastric Reflux, Barrett's Esophagus, etc.)

2.3.2. Gastric Microbiota

2.3.2.1. Healthy Individuals
2.3.2.2. Patients (Gastric Ulcer, Gastric Cancer, MALT, etc)

2.3.3. Gallbladder Microbiota

2.3.3.1. Healthy Individuals
2.3.3.2. Patients (Cholecystitis, Cholelithiasis, etc.)

2.3.4. Small Intestine Microbiota

2.3.4.1. Healthy Individuals
2.3.4.2. Patients (Inflammatory Bowel Disease, Irritable Bowel Syndrome, etc.)

2.3.5. Colon Microbiota

2.3.5.1. Healthy Individuals. Enterotypes
2.3.5.2. Patients (Inflammatory Bowel Disease, Crohn's Disease, Colon Carcinoma, Appendicitis, etc..

2.4. Gut Microbiota Functions: Metabolic. Nutritional and Trophic. Protective and Barrier. Immunological

2.4.1. Interrelationships Between the Gut Microbiota and Distant Organs (Brain, Lung, Heart, Liver, Pancreas, etc.)

2.5. Intestinal Mucosa and Mucosal Immune System

2.5.1. Anatomy, Characteristics, and Functions (MALT, GALT, and BALT System)

2.6. What is Intestinal Homeostasis? Role of Bacteria in Intestinal Homeostasis

2.6.1. Effects on Digestion and Nutrition
2.6.2. Defence Stimulation, Hindering Colonization by Pathogenic Microorganisms
2.6.3. Production of Vitamin B and K
2.6.4. Production of Short Chain Fatty Acids (Butyric, Propionic, Acetic, etc.)
2.6.5. Production of Gases (Methane, Carbon Dioxide, Molecular Hydrogen). Properties and Functions
2.6.6. Lactic Acid

Module 3. Gut Microbiota II. Intestinal Dysbiosis

3.1. What is Intestinal Dysbiosis? Consequences
3.2. Intestinal Barrier. Physiology. Function. Intestinal Permeability and Hyperpermeability. Relationship between Intestinal Dysbiosis and Intestinal Hyperpermeability
3.3. Relationship of Intestinal Dysbiosis and Other Types of Disorders: Immunological, Metabolic, Neurological and Gastric (Helicobacter Pylori)
3.4. Consequences of the Alteration of the Intestinal Ecosystem and its Relationship to Functional Digestive Disorders

3.4.1. Inflammatory Bowel Disease IBD
3.4.2. Chronic Inflammatory Bowel Diseases: Crohn's Disease. Ulcerative Colitis
3.4.3. Irritable Bowel Syndrome (IBS) and Diverticulitis
3.4.4. Intestinal Motility Disorders. Diarrhea. Diarrhea Caused by Clostridium Difficile. Constipation
3.4.5. Digestive Disorders and Nutrient Malabsorption Problems: Carbohydrates, Proteins, and Fats
3.4.6. Markers of Intestinal Inflammation: Calprotectin. Eosinophil Cationic Protein (ECP). Lactoferrin. Lysozyme.
3.4.7. Leaky Gut Syndrome. Permeability Markers: Alpha-1 Antitrypsin. Zonulin. Tight Junctions and their Main Function.

3.5. Alteration of the Intestinal Ecosystem and its Relationship with Intestinal Infections

3.5.1. Viral Intestinal Infections
3.5.2. Bacterial Intestinal Infections
3.5.3. Intestinal Infections due to Parasites
3.5.4. Fungal Intestinal Infections. Intestinal Candidiasis.

3.6. Composition of the Gut Microbiota in the Different Stages of Life

3.6.1. Variation in Gut Microbiota Composition from the Neonatal-Early Childhood Stage to Adolescence. “Unstable Period”
3.6.2. Composition of the Gut Microbiota Microbiota in Adulthood. “Stable Period”
3.6.3. Gut Microbiota Composition in the Elderly "Unstable Stage". Aging and Microbiota

3.7. Nutritional Modulation of Intestinal Dysbiosis and Hyperpermeability: Glutamine, Zinc, Vitamins, Probiotics, Prebiotics
3.8. Techniques for Quantitative Analysis of Microorganisms in Feces
3.9. Current Lines of Research

Module 4. Microbiota in Neonatology and Pediatrics

4.1. Mother-Child Symbiosis
4.2. Influencing Factors on the Gut Microbiota of the Mother during Pregnancy and during Birth. Influence of the Type of Delivery on the Microbiota of the New-born
4.3. Type and Duration of Breastfeeding, Influence on the Infant’s Microbiota

4.3.1. Breast Milk: Composition of the Breast Milk Microbiota. Importance of Breastfeeding in the New-born’s Microbiota
4.3.2. Artificial Breastfeeding. Use of Probiotics and Prebiotics in Infant Milk Formulas

4.4. Clinical Applications of Probiotics and Prebiotics in Pediatric Patients

4.4.1. Digestive Diseases: Functional Digestive Disorders, Diarrhea, Necrotizing Enterocolitis. Intolerances
4.4.2. Non-digestive Pathologies: Respiratory and ENT, Atopic Diseases, Metabolic Diseases. Allergies

4.5. Influence of Antibiotic and other Psychotropic Treatment on the Microbiota of the Infant
4.6. Current Lines of Research

Module 5. Oral Microbiota and Respiratory Tract

5.1. Structure and Oral Ecosystems

5.1.1. Main Oral Ecosystems
5.1.2. Key Points

5.2. Main Ecosystems that are Found in the Oral Cavity. Characteristics and Composition of Each of Them. Nostrils, Nasopharynx and Oropharynx

5.2.1. Anatomical and Histological Features of the Oral Cavity
5.2.2. Nasal Fossa
5.2.3. Nasopharynx and Oropharynx

5.3. Alterations of the Oral Microbial Ecosystem: Oral Dysbiosis. Relationship with Different Oral Disease States

5.3.1. Characteristics of Oral Microbiota
5.3.2. Oral Diseases
5.3.3. Recommended Measures to Reduce Dysbiotic Processes

5.4. Influence of External Agents in Oral Eubiosis and Dysbiosis. Hygiene

5.4.1. Influence of External Agents in Oral Eubiosis and Dysbiosis
5.4.2. Oral Symbiosis and Dysbiosis
5.4.3. Predisposing Factors to Oral Dysbiosis

5.5. Structure of the Respiratory Tract and Composition of the Microbiota and Microbiome

5.5.1. Upper Respiratory Routes
5.5.2. Lower Respiratory Routes

5.6. Factors that Regulate the Respiratory Microbiota

5.6.1. Metagenomics
5.6.2. Hypothesis of Hygiene
5.6.3. Viroma
5.6.4. Microbiome or Fungiome
5.6.5. Probiotics in Bronchial Asthma
5.6.6. Diet
5.6.7. Prebiotics
5.6.8. Bacterial Translocation

5.7. Alteration of the Respiratory Tract Microbiota and its Relationship with Different Respiratory Tract Diseases

5.7.1. Pathogenesis and Clinical Manifestations of Upper Respiratory Tract Infections
5.7.2. Pathogenesis and Clinical Manifestations of Upper Respiratory Tract Infections

5.8. Therapeutic Manipulation of the Microbiome of the Oral Cavity in Prevention and Treatment of Diseases Related to it

5.8.1. Definition of Probiotics, Prebiotics, and Symbiotics
5.8.2. Application for Oral Cavity Probiotic
5.8.3. Probiotic Strains Used in the Mouth
5.8.4. Action in Relation to Oral Diseases

5.9. Therapeutic Manipulation of the Microbiome of the Respiratory Tract in Prevention and Treatment of Related Diseases

5.9.1. Efficacy of Probiotics for the Treatment of Respiratory Tract Disease: Gut-Lung-Respiratory Axis
5.9.2. Use of Probiotics for the Treatment of Rhinosinusitis
5.9.3. Use of Probiotics for the Treatment of Otitis
5.9.4. Use of Probiotics for the Treatment of Upper Respiratory Infections
5.9.5. Use of Probiotics in Rhinitis and Allergic Bronchial Asthma
5.9.6. Probiotics to prevent lower respiratory tract infections
5.9.7. Studies with Lactobacilli
5.9.8. Studies with Bifidobacteria

5.10. Current Lines of Research and Clinical Applications

5.10.1. Transfer of Fecal Material
5.10.2. Extraction of Nucleic Acids
5.10.3. Sequencing Methods
5.10.4. Strategies for Microbiota Characterization
5.10.5. Metataxonomy
5.10.6. Metataxonomy of the Active Fraction
5.10.7. Metagenomics
5.10.8. Metabolomics

Module 6. Microbiota and Immune System

6.1. Immune System Physiology

6.1.1. Immune System Components

6.1.1.1. Lymphoid Tissue
6.1.1.2. Immune Cells
6.1.1.3. Chemical Systems

6.1.2. Organs Involved in Immunity

6.1.2.1. Primary Organs
6.1.2.2. Secondary Organs

6.1.3. Innate, Non-Specific, or Natural Immunity
6.1.4. Acquired, Adaptive, or Specific Immunity

6.2. Nutrition and Lifestyle
6.3. Functional Foods (Probiotics and Prebiotics), Nutraceuticals, and Immune System

6.3.1. Probiotics, Prebiotics, and Symbiotics
6.3.2. Nutraceuticals and Functional Foods

6.4. Bidirectional Relationship between Microbiota and Neuroimmunoendocrine System
6.5. Microbiota, Immunity and Nervous System Disorders
6.6. The Gut-Microbiota-Brain Axis
6.7. Current Lines of Research

Module 7. Skin Microbiota

7.1. Skin Physiology

7.1.1. Structure of the Skin: Epidermis, Dermis, and Hypodermis
7.1.2. Functions of the Skin
7.1.3. Microbial Composition of the Skin

7.2. Factors that Regulate the Type of Bacterial Flora in the Skin

7.2.1. Sweat Glands, Sebaceous Glands, Desquamation
7.2.2. Factors that Alter the Ecology of the Skin and its Microbiota

7.3. Skin Immune System. Epidermis; Essential Element of our Defences

7.3.1. Epidermis; Essential Element of our Defences
7.3.2. Elements of the Cutaneous Immune System: Cytosines, Keratinocytes, Dendritic Cells, Lymphocytes, Antimicrobial Peptides
7.3.3. Influence of the Skin Microbiota on the Skin Immune System. Staphylococcus Epidermidis, Staphylococcus Aureus

7.4. Alteration of the Normal Cutaneous Microbiota (Dysbiosis) and Alteration of the Barrier Function

7.4.1. Impaired Barrier Function

7.5. Triggered Skin Diseases

7.5.1. Psoriasis (Streptococcus Pyogenes)
7.5.2. Acne Vulgaris
7.5.3. Atopic Dermatitis
7.5.4. Rosacea

7.6. Influence of the use of Probiotics in the Prevention and Treatment of Different Skin Diseases
7.7. Current Lines of Research

Module 8. Genitourinary Tract Microbiota

8.1. Physiology of the Genitourinary Tract in Men and Women
8.2. Microorganisms Causing Genitourinary Infections

8.2.1. Enteric Bacteria, Generally Gram-Negative Aerobic Bacteria: E. Coli, Enterobacteria. Klebsiella or Proteus Mirabilis or Pseudomonas Aeruginosa
8.2.2. Gram-Positive Bacteria: Staphylococcus Saprophyticus, etc.

8.3. Vaginal Microbiota and its Modification with Age

8.3.1. Infant Age
8.3.2. Fertile Age
8.3.3. Adult Age (Menopause)

8.4. Alteration of the Vaginal Homeostasis and its Relationship with Infectious Pathologies

8.4.1. Infectious Vaginitis

8.4.1.1. Chlamydia
8.4.1.2. Bacterial Vaginosis
8.4.1.3. Vaginal Candidiasis
8.4.1.4. Vaginitis Trichomoniasis
8.4.1.5. Viral Vaginitis

8.4.2. Non-Infectious Vaginitis

8.5. Probiotics in the Prevention of Major Genitourinary Tract Infections
8.6. Current Lines of Research

Module 9. The Relationship between Intolerances/Allergies and the Microbiota

9.1. Microbiota Changes in Patients on Food Exclusion Diets

9.1.1. Eosinophilic Esophagitis (EoE)

9.2. Changes in the Microbiota in Patients with Food Exclusion Diets: Intolerance to Dairy Products (Lactose, Milk Proteins: Caseins, Albumins, Others)

9.2.1. Lactose Intolerance
9.2.2. Intolerant to Lactic Proteins: Caseins, Albumins, etc.
9.2.3. People Allergic to Milk

9.3. Alteration and Recovery of the Gut Microbiota in Patients with Gluten Intolerance and Celiac Disease

9.3.1. Alteration of the Gut Microbiota in Patients with Gluten Intolerance
9.3.2. Alteration of the Gut Microbiota in Celiac Patients
9.3.3. Role of Probiotics and Prebiotics in the Recovery of the Microbiota in Gluten Intolerant and Celiac Patients

9.4. Microbiota and Biogenic Amines
9.5. Current Lines of Research

Module 10. Probiotics, Prebiotics, Microbiota, and Health

10.1. Probiotics
10.2. Prebiotics
10.3. Clinical Applications of Probiotics and Prebiotics in Gastroenterology
10.4. Clinical Applications of Endocrinology and Cardiovascular Disorders
10.5. Clinical Applications of Probiotics and Prebiotics in Urology
10.6. Clinical Applications of Probiotics and Prebiotics in Gynecology
10.7. Clinical Applications of Probiotics and Prebiotics in Immunology
10.8. Clinical Applications of Probiotics and Prebiotics in Nutritional Diseases
10.9. Clinical Applications of Probiotics and Prebiotics in Neurological Diseases
10.10. Clinical Applications of Probiotics and Prebiotics in Critically Ill Patients
10.11. Dairy Products as a Natural Source of Probiotics and Prebiotics
10.12. Safety and Legislation in the Use of Probiotics

Relearning, TECH's didactic method of excellence, will guarantee you a fast and flexible mastery of the complex contents of this Hybrid professional master’s degree"